Skip to main content
Frontiers in Endocrinology logoLink to Frontiers in Endocrinology
. 2026 Feb 25;17:1727260. doi: 10.3389/fendo.2026.1727260

Changes of retinal microvascular parameters in patients with type 2 diabetes mellitus with or without diabetic kidney disease

Ruirui Ma 1,2, Chunwen Zheng 3, Yuling Niu 1,2, Duanrong Cao 1,2, Yijun Hu 1,2,4,*, Ling Jin 1,2,*
PMCID: PMC12975603  PMID: 41821728

Abstract

Purpose

To investigate the quantitative retinal microvascular parameters in patients with type 2 diabetes mellitus (T2DM) with or without diabetic kidney disease (DKD).

Methods

This retrospective study included 117 T2DM patients with DKD (DKD group) and 179 T2DM patients without DKD (non-DKD group). Quantitative retinal microvascular parameters were extracted from fundus photographs by an artificial intelligence (AI) system, including the number of retinal lesions (hard exudates, cotton wool spots, hemorrhagic spots, and microaneurysms), mean branch angle, fractal dimension (FD), mean vessel diameter (MVD), mean arterial diameter (MAD), mean venular diameter (MVeD), arteriole-to-venule ratio (AVR), mean vessel tortuosity (MVT), mean arterial tortuosity (MAT), mean venular tortuosity (MVeT), vessel density (VD), VD within the 3-mm and 5-mm foveal avascular zones (FAZ), and cup-to-disc area ratio (CDR). Systemic parameters were also collected, including systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting plasma glucose (FPG), duration of T2DM, glycated hemoglobin (HbA1c), triglyceride (TG), total cholesterol (CHOL), bicarbonate (HCO3), blood urea nitrogen (BUN), uric acid (UA), creatinine, cystatin C, and estimated glomerular filtration rate (eGFR). Group comparisons were performed using t-test or Mann-Whitney test. Univariable and multivariable logistic regression analyses were used to determine the parameters associated with DKD.

Results

Multiple retinal parameters were significantly different between the two groups, including numbers of hard exudates, cotton wool spots, microaneurysms, hemorrhagic spots, FD, MVD, MVeD, VD, and VD within the 3-mm and 5-mm FAZ (all P < 0.05). Univariable logistic regression analysis demonstrated significant associations between DKD risk and the following variables: SBP, BUN, HCO3, eGFR, creatinine, UA, cystatin C, duration of T2DM, staging of diabetic retinopathy (DR), number of cotton wool spots, microaneurysms, FD, MVD, MVeD, VD, and VD within 3-mm and 5-mm FAZ (all P < 0.05). Multivariable logistic regression analysis found that age (OR = 0.971, 95% CI: 0.948–0.994, P = 0.013), SBP (OR = 1.015, 95% CI: 1.002–1.029, P = 0.027), duration of T2DM (OR = 1.056, 95% CI: 1.019-1.095, P = 0.003), staging of DR (OR = 1.287, 95% CI: 1.064-1.557, P = 0.009), and VD within 3-mm radius of FAZ (OR = 0.000, 95% CI: 0.000-0.000, P < 0.001), were independent risk factors of DKD.

Conclusion

Quantitative retinal microvascular parameters derived from fundus photographs show potential for identifying T2DM patients at risk of DKD, supporting the future use of retinal parameters as a non-invasive tool for early detection of renal impairment in patients with T2DM.

Keywords: diabetes kidney disease, diabetic retinopathy, microvascular complications, retinal vasculature, type 2 diabetes mellitus

Introduction

Type 2 diabetes mellitus (T2DM) is a globally prevalent endocrinological disorder, with its elevated incidence and high disability rate posing an urgent public health challenge to human health and the global economy. Studies estimate that the global prevalence of T2DM will reach 783.2 million individuals by 2045 (1, 2). Among its serious microvascular complications, diabetic kidney disease (DKD) is a leading cause of end-stage renal disease worldwide (3). DKD develops in approximately 30% to 40% of diabetic patients and is well-known to be associated with a markedly increased risk of mortality (4).

Current conventional screening for DKD primarily relies on invasive and resource-intensive methods, such as renal function tests and kidney biopsies. Pathophysiological studies indicate that prolonged hyperglycemia, hypertension, and oxidative stress in diabetic patients collectively contribute to systemic microvascular changes, including vascular remodeling and vasodilation, leading to renal impairment and other microvascular complications (5, 6). Similar risk factors also contribute to the retinal vascular changes. It was shown that increased nighttime SBP is a critical factor affecting retinal arteriovenous ratio in T2DM patients (7). Diabetes was shown to modify the associations between retinal venular tortuosity and cardiometabolic risk factors (8). Given the shared microvascular pathology, a strong correlation has been established between DKD and diabetic retinopathy (DR) (9). Retinal microvascular alterations have been shown to correlate with renal dysfunction, suggesting that retinal imaging could serve as a non-invasive surrogate for evaluating the renal involvement in patients with diabetes (1012). A previous study has shown that both duration of diabetes and urinary albumin levels are significantly correlated with retinal mean vessel density of whole superficial capillary plexus in diabetic patients (10). In another study, estimated glomerular filtration rate was correlated significantly with macular avascular zones area in patients with T2DM (12). Moreover, the presence and severity of DR have been recognized as significant risk factors of DKD, highlighting the potential of retinal microvascular assessment in risk stratification for DKD in diabetic patients (13). Advances in artificial intelligence (AI) have also enabled the quantitative analysis of retinal microvascular parameters from fundus photographs, providing a rapid, non-invasive, and cost-effective imaging modality for screening.

This study aims to investigate the correlation between quantitative retinal microvascular parameters extracted from fundus photographs and the presence of DKD in patients with T2DM. Our findings may offer theoretical support for early detection of renal microvascular damage using accessible retinal imaging in this population.

Materials and methods

Study population

A total of 117 T2DM patients with DKD (DKD group) and 179 T2DM patients without DKD (non-DKD group) were recruited retrospectively from the Department of Ophthalmology at People’s Hospital of Baoan, Shenzhen between January 2022 and December 2024. The study protocol was approved by the Institutional Review Board (IRB) of People’s Hospital of Baoan Shenzhen and strictly adhered to the principles of the Declaration of Helsinki. Written informed consent was waived by the IRB, given that the study was conducted retrospectively and only involved existing clinical images and data, without compromising the patients’ privacy.

Medical records of patients with T2DM referred to our department for routine consultation were reviewed consecutively for inclusion. The inclusion criteria were as follows:

DKD group: T2DM patients with DKD diagnosed according to the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease, including elevation of urinary albumin-to-creatinine ratio (UACR) ≥ 3 mg/mmol, or a progressive decrease in eGFR < 60 mL/min/1.73 m2, or both, persistent for greater than 3 months (1416).

Non-DKD group: T2DM patients who met the American Diabetes Association diagnostic criteria (17), but had no clinical evidence of DKD such as albuminuria and abnormal renal biochemistry (UACR < 3 mg/mmol, and eGFR ≥ 60 ml/min per 1.73 m2) (1416).

Exclusion criteria applied to all participants included: 1) diagnosis of type 1 diabetes or other specific types of diabetes; 2) renal impairment attributed to non-diabetic etiologies; 3) severe hypertensive retinopathy; 4) coexisting any other types of ocular diseases (e.g., severe cataract, high myopia, optic neuropathy, glaucoma, uveitis, or other retinal vascular disorders such as retinal vein/artery occlusion); 5) history of any types of ocular surgery (e.g., vitrectomy); 6) history of any types of immune-related diseases (e.g., systemic lupus erythematosus).

Data collection

Demographic information and clinical data of the patients were collected, including gender, age, duration of hypertension (HTN), and duration of T2DM. All patients underwent comprehensive ophthalmic examinations, including slit-lamp examination, best-corrected visual acuity, and intraocular pressure (IOP) measurement.

For retinal microvascular analysis, macula-centered 50-degree fundus photographs were captured from both right and left eyes using a Topcon fundus camera (TRC-50DX, Topcon Corperation, Tokyo, Japan) by trained ophthalmic technicians. The image from the right eye of every patient was selected for analysis; if its image quality was suboptimal, the image of the left eye was used instead. The severity of DR was graded using a standard protocol (18). Quantitative retinal microvascular parameters were extracted using the EVision AI System (19), which is an AI-based digital image analysis software used to quantify vascular features. The assessed parameters included: number of hard exudates, number of cotton wool spots, number of hemorrhagic spots, number of microaneurysms, mean branch angle, fractal dimension (FD), mean vessel diameter (MVD), mean arterial diameter (MAD), mean venular diameter (MVeD), arteriole-to-venule ratio (AVR), mean vessel tortuosity (MVT), mean arterial tortuosity (MAT), mean venular tortuosity (MVeT), vessel density (VD), VD within the 3-mm and 5-mm foveal avascular zone (FAZ), and cup-to-disc area ratio (CDR).

The EVision AI System has been described in previous publications (19, 20). The fundus photos were processed by establishment the region of interest (ROI), denoising, normalization, and enhancement. Then the processed images were put into a deep learning network for segmentation of the retinal vessels. The quantitative retinal microvascular parameters were calculated and extracted as output. Segmentation of the retinal vessels in the two groups are shown in Figure 1.

Figure 1.

Side-by-side retinal fundus images compare Non-DKD and DKDeyes. Both display blood vessels highlighted in blue and pink, with concentric circles centered on the macula, illustrating structural and vascular differences for clinical analysis.

Segmentation of the retinal vessels in the two group.

Systemic parameters were measured from venous blood samples collected after an 8-hour fasting period. These parameters included systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), triglyceride (TG), total cholesterol (CHOL), bicarbonate (HCO3), blood urea nitrogen (BUN), uric acid (UA), estimated glomerular filtration rate (eGFR), and cystatin C.

Statistical analysis

Group differences in demographics, medical history, systemic parameters, and retinal parameters were assessed. Categorical variables were presented as numbers and percentages and compared between groups using the Chi-square test. Continuous variables were tested for normality; those conforming to a normal distribution were expressed as mean ± standard deviation (SD) and compared using independent samples t-tests, while non-normally distributed data were presented as median and interquartile range (IQR) and compared using the Mann-Whitney U test.

To identify factors associated with DKD, univariable logistic regression analyses were first conducted. Variables showing statistical significance (P < 0.05) in the univariable analysis were subsequently included in a multivariable logistic regression model. The variance inflation factor (VIF) was calculated to assess multicollinearity among the included variables. A two-sided P value of less than 0.05 was considered statistically significant. All statistical analyses were performed using IBM SPSS Statistics version 24.

Results

Baseline characteristics

A total of 296 participants were included in this study, comprising 117 T2DM patients with DKD (DKD group) and 179 T2DM patients without DKD (non-DKD group). The comparative analysis of baseline demographic and systemic parameters is summarized in Table 1; Supplementary Table S1. Patients in the DKD group had a longer duration of T2DM and HTN, along with higher DR staging, SBP, TG levels, BUN levels, UA levels, and cystatin C levels, but lower HCO3- levels and eGFR (all P < 0.05). In contrast, no significant differences were found in age, gender distribution, DBP, CHOL, FPG, or HbA1c levels (all P > 0.05) between DKD and non-DKD groups.

Table 1.

Descriptive analysis of baseline characteristics in the two groups.

Parameter DKD group (n=117) Non-DKD group (n=179) P value
Gender (male/female) 81/36 115/64 0.377
SBP (mmHg) 136.00 (26.50) 128.00 (26.00) 0.001
DBP (mmHg) 79.56 ± 9.95 79.78 ± 10.41 0.856
Age (years) 56.63 ± 11.83 56.96 ± 11.48 0.813
TG (mmol/L) 1.80 (1.38) 1.55 (1.39) 0.049
CHOL (mmol/L) 4.85 (1.70) 4.88 (2.00) 0.849
BUN (mmol/L) 7.60 (4.95) 5.10 (2.04) <0.001
HCO3 (mmol/L) 23.47 (4.29) 24.63 (3.49) 0.002
Creatinine (μmol/L) 108.10 (113.20) 68.65 (27.71) <0.001
eGFR (ml/min/1.73 m2) 54.43 (58.15) 102.60 (33.11) <0.001
UA (μmol/L) 401.10 (187.40) 357.90 (130.90) <0.001
Cystatin C (mg/L 1.38 (1.30) 1.00 (0.24) <0.001
FPG (mmol/L) 7.91 (5.56) 7.85 (4.98) 0.519
Duration of HTN (years) 0.00 (3.00) 0.00 (0.00) 0.014
Duration of T2DM (years) 10.00 (9.50) 6.00 (9.00) <0.001
HbA1c (%) 8.30 (3.10) 8.50 (4.00) 0.301

Presented as mean ± standard deviation (SD) or median (interquartile range, IQR) and bold number indicates P < 0.05; DKD, diabetic kidney disease; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride; CHOL, total cholesterol; BUN, blood urea nitrogen; HCO3, bicarbonate; eGFR, estimated glomerular filtration rate; UA, uric acid; FPG, fasting plasma glucose; HTN, hypertension; T2DM, type 2 diabetes mellitus; HbA1c, hemoglobin A1c.

Comparisons of retinal parameters between DKD and non-DKD groups

The comparison of retinal vascular parameters between the DKD and non-DKD groups is detailed in Table 2. Significant differences were identified in several retinal parameters between the two groups. Specifically, the DKD group exhibited worse corrected visual acuity (LogMAR) and a greater number of retinal lesions, including hard exudates, cotton wool spots, microaneurysms, and hemorrhagic spots. Furthermore, retinal microvascular morphology and density also differed; the DKD group demonstrated a lower FD, a larger MVD and MVeD, lower overall VD, and lower VD within both the 3-mm and 5-mm radii of the FAZ (all P < 0.05). However, no statistically significant differences were observed between the two groups in IOP, mean branch angle, MVT, MAT, MVeT, AVR, or CDR (all P > 0.05).

Table 2.

Comparative analysis of retinal parameters between the two groups.

Parameter DKD group (n=117) Non-DKD group (n=179) P value
Corrected visual acuity 0.10 (0.22) 0.00 (0.10) 0.005
IOP (mmHg) 15.00 (4.75) 15.00 (4.00) 0.712
Number of hard exudates 2.00 (18.00) 0.00 (4.00) <0.001
Number of cotton wool spots 0.00 (1.00) 0.00 (0.00) <0.001
Number of microaneurysms 17.00 (23.50) 10.00 (16.00) <0.001
Number of hemorrhagic spots 2.00 (11.00) 0.00 (3.00) <0.001
mean branch angle 66.15 (7.44) 66.26 (7.26) 0.775
FD 1.51 (0.09) 1.53 (0.06) <0.001
MVD (um) 62.54 (9.26) 60.51 (7.78) 0.005
MAD (um) 54.99 (9.23) 54.69 (7.79) 0.482
MVeD (um) 71.89 (11.44) 68.44 (10.05) 0.001
MVT 0.86 (0.16) 0.84 (0.08) 0.289
MAT 0.64 (0.11) 0.64 (0.15) 0.995
MVeT 1.01 (0.26) 0.98 (0.22) 0.536
VD 0.07 (0.03) 0.08 (0.02) <0.001
VD within 3-mm radius of FAZ 0.05 (0.03) 0.06 (0.02) <0.001
VD within 5-mm radius of FAZ 0.07 (0.03) 0.08 (0.02) <0.001
AVR 0.76 (0.12) 0.78 (0.12) 0.102
CDR 0.22 (0.11) 0.22 (0.11) 0.192

Presented as mean ± standard deviation (SD) or median (interquartile range, IQR) and bold number indicates P < 0.05; DKD, diabetic kidney disease; IOP, intraocular pressure; FD, fractal dimension; MVD, mean vessel diameter; MAD, mean arterial diameter; MVeD, mean venular diameter; MVT, mean vessel tortuosity; MAT, mean arterial tortuosity; MVeT, mean venular tortuosity; VD, vessel density; FAZ, foveal avascular zone; AVR, arteriole-to-venule diameter ratio; CDR, cup-to-disc area ratio.

Univariable logistic regression analysis of baseline characteristics between DKD and non-DKD groups

For systemic parameters, univariable logistic regression analysis revealed that several factors were significantly associated with the presence of DKD. As shown in Table 3, SBP (OR = 1.023, 95% CI: 1.009–1.037, P = 0.002), duration of T2DM (OR = 1.060, 95% CI: 1.022–1.099, P = 0.002), levels of serum creatinine (OR = 1.043, 95% CI: 1.030–1.056, P < 0.001), BUN (OR = 1.524, 95% CI: 1.337–1.737, P < 0.001), HCO3 (OR = 0.902, 95% CI: 0.839–0.971, P = 0.006), eGFR (OR = 0.954, 95% CI: 0.942–0.966, P < 0.001), UA (OR = 1.004, 95% CI: 1.002–1.006, P < 0.001).

Table 3.

Univariable logistic regression analysis of baseline characteristics.

Independent variables OR 95% CI P value
Gender 1.252 (0.761, 2.059) 0.376
SBP (mmHg) 1.023 (1.009, 1.037) 0.002
DBP (mmHg) 0.998 (0.975, 1.021) 0.855
Age (years) 0.998 (0.978, 1.018) 0.812
TG (mmol/L) 1.042 (0.943, 1.150) 0.421
CHOL (mmol/L) 1.012 (0.892, 1.148) 0.853
BUN (mmol/L) 1.524 (1.337, 1.737) <0.001
HCO3 (mmol/L) 0.902 (0.839, 0.971) 0.006
eGFR (ml/min/1.73 m2) 0.954 (0.942, 0.966) <0.001
Creatinine (μmol/L) 1.043 (1.030, 1.056) <0.001
UA (μmol/L) 1.004 (1.002, 1.006) <0.001
Cystatin C (mg/L) 11.677 (4.882, 27.930) <0.001
FPG (mmol/L) 0.973 (0.921, 1.029) 0.341
Duration of T2DM (years) 1.060 (1.022, 1.099) 0.002
HbA1c (%) 0.939 (0.850, 1.036) 0.209
Duration of HTN (years) 1.037 (0.989, 1.086) 0.132

Presented as Odds Ratio (95% confidence interval) with the two groups as the dependent variable; Bold number indicates P<0.05; CI, confidence interval; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride; CHOL, total cholesterol; BUN, blood urea nitrogen; HCO3, bicarbonate; eGFR, estimated glomerular filtration rate; UA, uric acid; FPG, fasting plasma glucose; T2DM, type 2 diabetes mellitus; HbA1c, hemoglobin A1c; HTN, hypertension.

In contrast, no significant associations were observed between the risk of DKD and the following systemic parameters, including gender, DBP, age, TG, CHOL, FPG, duration of HTN, or HbA1c (all P > 0.05).

Univariable logistic regression analysis of retinal microvascular parameters between DKD and non-DKD groups

For retinal parameters, findings of univariable logistic regression analysis were demonstrated in Table 4. Results showed that more serious Staging of DR (OR = 1.573, 95% CI: 1.325–1.867, p < 0.001), a higher number of cotton wool spots (OR = 1.360, 95% CI: 1.127–1.642, P = 0.001), a higher number of microaneurysms (OR = 1.011, 95% CI: 1.001–1.022, P = 0.037), lower FD (OR = 0.000, 95% CI: 0.000–0.002, P < 0.001), larger MVD (OR = 1.052, 95% CI: 1.017–1.089, P = 0.003), larger MVeD (OR = 1.044, 95% CI: 1.015–1.074, P = 0.003), lower VD (OR = 0.000, 95% CI: 0.000–0.000, p < 0.001), lower VD within 3-mm radius of FAZ (OR = 0.000, 95% CI: 0.000–0.000, p< 0.001), and lower VD within 5-mm radius of FAZ (OR = 0.000, 95% CI: 0.000–0.000, P < 0.001) were significantly associated with an increased risk of DKD (all P < 0.05).

Table 4.

Univariable logistic regression analysis of retinal microvascular parameters.

Independent variables OR 95% CI P value
Corrected Visual acuity 1.178 (0.458, 3.033) 0.734
IOP (mmHg) 1.012 (0.939, 1.091) 0.754
Staging of DR 1.573 (1.325, 1.867) <0.001
Number of hard exudates 1.004 (0.999, 1.009) 0.140
Number of cotton wool spots 1.360 (1.127, 1.642) 0.001
Number of microaneurysms 1.011 (1.001, 1.022) 0.037
Number of hemorrhagic spots 1.013 (0.997, 1.030) 0.108
mean branch angle 0.987 (0.953, 1.023) 0.478
FD 0.000 (0.000, 0.002) <0.001
MVD (um) 1.052 (1.017, 1.089) 0.003
MAD (um) 1.019 (0.986, 1.053) 0.253
MVeD (um) 1.044 (1.015, 1.074) 0.003
MVT 3.009 (0.468, 19.329) 0.246
MAT 1.160 (0.178, 7.540) 0.877
MVeT 1.647 (0.437, 6.202) 0.461
VD 0.000 (0.000, 0.000) <0.001
VD within 3-mm radius of FAZ 0.000 (0.000, 0.000) <0.001
VD within 5-mm radius of FAZ 0.000 (0.000, 0.000) <0.001
AVR 0.088 (0.008, 1.019) 0.052
CDR 0.280 (0.016, 5.034) 0.388

Presented as Odds Ratio (95% confidence interval, 95% CI) with the two groups as the dependent variable; Bold number indicates P < 0.05; CI, confidence interval; IOP, intraocular pressure; DR, diabetic retinopathy; FD, fractal dimension; MVD, mean vessel diameter; MAD, mean arterial diameter; MVeD, mean venular diameter; MVT, mean vessel tortuosity; MAT, mean arterial tortuosity; MVeT, mean venular tortuosity; VD, vessel density; FAZ, foveal avascular zone; AVR, arteriole-to-venule diameter ratio; CDR, cup-to-disc area ratio.

In contrast, retinal parameters such as corrected visual acuity (LogMAR), IOP, number of hard exudates, number of hemorrhagic spots, mean branch angle, MAD, MVT, MAT, MVeT, AVR, and CDR were not significantly associated with the incidence of DKD (all P > 0.05).

Multivariable logistic regression analysis for the determinants of DKD

Variables that were significant in the univariable analyses were included in a multivariable logistic regression model to identify independent determinants of DKD (Table 5). After adjustment, five factors remained independently associated with the risk of DKD: a younger age (OR = 0.971, 95% CI: 0.948–0.994, P = 0.013), a higher SBP (OR = 1.015, 95% CI: 1.002–1.029, P = 0.027), a longer duration of T2DM (OR = 1.056, 95% CI: 1.019-1.095, P = 0.003), a higher DR staging (OR = 1.287, 95% CI: 1.064-1.557, P = 0.009), and lower VD within 3-mm radius of FAZ (OR = 0.000, 95% CI: 0.000-0.000, P < 0.001). Notably, retinal microvascular parameters, including gender, number of cotton wool spots, MVD, and MVeD, which were significant in univariable analysis, lost their independent significance in the multivariable model (all P > 0.05).

Table 5.

Multivariable logistic regression analysis for the determinants of DKD.

Independent variables OR 95% CI P value
Age (years) 0.971 (0.948, 0.994) 0.013
Gender 0.700 (0.439, 1.114) 0.132
SBP (mmHg) 1.015 (1.002, 1.029) 0.027
T2DM duration (years) 1.056 (1.019, 1.095) 0.003
Staging of DR 1.287 (1.064, 1.557) 0.009
Number of cotton wool spots 1.138 (0.924, 1.401) 0.224
MVD (um) 1.024 (0.959, 1.094) 0.479
VD within 3-mm radius of FAZ 0.000 (0.000, 0.000) <0.001
MVeD (um) 0.968 (0.914, 1.026) 0.274

Presented as Odds Ratio (95% confidence interval, 95% CI) with the two groups as the dependent variable; Bold number indicates P<0.05; CI, confidence interval; DKD, diabetic kidney disease; SBP, systolic blood pressure; T2DM, type 2 diabetes mellitus; DR, diabetic retinopathy; MVD, mean vessel diameter; VD, vessel density; FAZ, foveal avascular zone; MVeD, mean venular diameter.

Discussion

DKD is a common and severe complication of diabetes, affecting approximately 40% of patients with diabetes (21). The pathophysiology of DKD is complex, involving multiple processes such as metabolic dysregulation, chronic inflammation, and fibrosis, contributing to substantial morbidity and mortality. The growing burden of DKD underscores the urgent need for identifying accessible, non-invasive assessment methods to evaluate the risks of DKD.

Given that retinal microvasculature can be observed directly and non-invasively, and DR and DKD are both microvascular complications of diabetes that share common mechanisms in microvascular injury pathways, retinal microvascular changes may serve as a window to systemic microangiopathy, including renal involvement (22, 23). Both complications arise from hyperglycemia-induced microvascular endothelial dysfunction, oxidative stress, inflammatory activation, and crosstalk between endothelial cells and pericytes/podocytes (24, 25). Previous studies have demonstrated a strong correlation between retinal microvascular alterations and the presence of DKD, with some evidence suggesting that DR may even precede clinical DKD onset (11, 12, 2629). In particular, retinal microcirculatory impairment has been reported to occur before the development of microalbuminuria (10). Therefore, this evidence highlights the potential of retinal microvascular parameters in monitoring renal microvascular damage of DKD.

In this study, we investigated the changes in quantitative retinal microvascular parameters in patients diagnosed as T2DM with or without DKD. Significant reductions in VD and FAZ density were observed in patients in the DKD group compared to those in the non-DKD group. Multivariable logistic regression analysis revealed that VD within the 3-mm FAZ was significantly associated with the risk of DKD. This finding aligns with previous reports of decreased VD in patients with DKD from multiple population-based studies (3032). The observed progressive capillary loss may be attributed to the complex mechanisms underlying DKD and its complications. The renin-angiotensin-aldosterone system exerts potent vasoconstrictive effects, potentially contributing to hemodynamic disturbances in retinal microvasculature (33). Oxidative stress and inflammatory responses in DKD may also accelerate retinal vascular endothelial injury (34). Additionally, as previously reported, anemia secondary to reduced erythropoietin production, uremic toxin accumulation, and dialysis in DKD may further exacerbate capillary damage (35).

Early endothelial dysfunction is considered a key initiating factor in diabetic microvascular complications (36). Consistent with this, our study found that significantly larger MVeD and MVD were observed in the DKD group compared to the non-DKD group. Univariable logistic regression analysis also indicated that MVeD and MVD were significantly associated with the risk of DKD. Similar findings were reported in previous studies demonstrating that retinal venular dilation positively correlates with DKD risk in diabetic patients (37, 38). This may be attributed to endothelial injury-mediated upregulation of vascular endothelial growth factor, leading to increased retinal vascular permeability, elevated intravascular blood volume, and vascular dilation with enhanced elasticity (39). Hyperglycemia reduces erythrocyte deformability and enhances aggregation, while endothelial injury further activates platelet and coagulation pathways, promoting a hypercoagulable state that may contribute to retinal venular dilation (40). Notably, our study observed significant differences in venular but not arterial diameter between DKD and non-DKD groups, which are consistent with other population-based studies (39, 40).

Systemic parameters also played a significant role. Previous studies have confirmed that hypertension exacerbates renal and retinal pathology in diabetic models (41). The coexistence of hypertension and diabetes significantly increases the risk of diabetic microvascular complications, including DKD and DR (42). In our study, we found that higher SBP and longer duration of T2DM were significantly associated with the risk of DKD, in line with prior studies (43). A UK prospective clinical trial confirmed that intensive blood pressure and glycemic control effectively reduce the incidence of DR and DKD (44). However, the precise mechanisms by which hypertension and diabetes interact to exacerbate DKD and DR remain unclear.

Retinal lesions were also evaluated in our study. Hard exudates, resulting from extravasation of fluid, lipids, and lipoproteins into the retinal layers from microaneurysms and dilated capillaries, were common in patients with DKD (45). Significant differences in the urine ACR were observed between groups with and without macular hard exudates (46). The underlying mechanisms linking renal dysfunction and hard exudates remain unclear but may involve concurrent injury to renal and retinal vascular cells, leading to blood-retinal barrier disruption and subsequent hard exudate formation (46). Interestingly, a previous study has reported resolution of hard exudates in the macular area after hemodialysis, suggesting that the formation of macular hard exudates may be partially associated with concurrent renal dysfunction (47). Similarly, cotton wool spot, which is a collection of axoplasmic material in the nerve fiber layer, is widely believed to be caused by retinal ischemia and is common in patients with DKD (48). It exhibits no specific differences in number, size, or distribution between diabetic or hypertensive patients alone, but is more prevalent when both conditions coexist (49).

We admit that this study has several limitations. First, its single-center, retrospective design, and relatively small sample size limit the generalizability. The small study population also limits our ability to balance the risk factors associated with retinal damage between the two study groups. Although we have used multivariable regression to adjust for the effects of these risk factors, the possible effects of selection bias should not be neglected. Future research should involve multi-center data with a prospective design and a larger population. Second, the study population consisted solely of Chinese individuals, and future multi-ethnic cohorts are needed to validate these findings. Additionally, we did not stratify patients by DKD severity. Hence, prospective studies including different stages of DKD and healthy controls would help clarify the progression of retinal changes. What is more, the standard protocol of fundus photography in our department was macula-centered, so we could only use the macula-centered image for analysis. Future studies using ultra-wide field imaging may provide more details about the retinal vascular changes in DKD. Last but not least, fluorescein fundus angiography (FFA) was not routinely performed in many of the study participants to evaluate the extent of retinal ischemia, either due to lower staging of DR or poor kidney function. Optical coherence tomography angiography (OCTA) was also not available in our department for more accurate measurement of the retinal vessels during the time of the study. In future studies, OCTA can be applied in these patients.

In conclusion, retinal abnormalities, specifically the VD within 3-mm FAZ and the staging of DR, are independently associated with renal impairment in patients with T2DM, after adjustment for important etiological confounding factors such as age, SBP, and duration T2DM. These findings support the potential use of AI-assisted fundus photograph analysis as a non-invasive tool for detecting renal microvascular damage in patients with T2DM, facilitating the identification of patients at higher risk of DKD for early intervention and improved risk stratification.

Funding Statement

The author(s) declared that financial support was received for this work and/or its publication. The study was funded by the Medical and Health Research Project of Bao’an District, Shenzhen (2025JD186).

Footnotes

Edited by: Yan Guo, The Second Military Medical University, China

Reviewed by: Barbara Nikolaidou, Aristotle University of Thessaloniki, Greece

Randa El-Mofty, Cairo University, Egypt

Houda Lajmi, Tunis El Manar University, Tunisia

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The studies involving humans were approved by Institutional Review Board (IRB) of People’s Hospital of Baoan Shenzhen. The studies were conducted in accordance with the local legislation and institutional requirements. The ethics committee/institutional review board waived the requirement of written informed consent for participation from the participants or the participants’ legal guardians/next of kin because the study was conducted retrospectively and only involved existing clinical images and data, without compromising the patients’ privacy.

Author contributions

RM: Writing – original draft, Data curation, Formal analysis, Investigation, Methodology. CZ: Writing – original draft, Conceptualization, Validation. YN: Data curation, Writing – review & editing. DC: Project administration, Writing – review & editing. YH: Formal analysis, Investigation, Methodology, Writing – review & editing, Conceptualization, Resources, Supervision. LJ: Investigation, Methodology, Conceptualization, Resources, Supervision, Writing – review & editing.

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fendo.2026.1727260/full#supplementary-material

Table1.docx (11.7KB, docx)

References

  • 1. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. (2022) 183:109119. doi:  10.1016/j.diabres.2021.109119, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Wang L, Peng W, Zhao Z, Zhang M, Shi Z, Song Z, et al. Prevalence and treatment of diabetes in China, 2013-2018. JAMA. (2021) 326:2498–506. doi:  10.1001/jama.2021.22208, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. (2004) 27:1047–53. doi:  10.2337/diacare.27.5.1047, PMID: [DOI] [PubMed] [Google Scholar]
  • 4. Mariampillai JE, Halvorsen LV, Larstorp AC, Heimark S, Waldum-Grevbo B, Kjeldsen SE, et al. Diabetes and chronic kidney disease. Tidsskr Nor Laegeforen. (2023) 143:10.4045/tidsskr.22.0822. [DOI] [PubMed] [Google Scholar]
  • 5. Sabanayagam C, Foo VH, Ikram MK, Huang H, Lim SC, Lamoureux EL, et al. Is chronic kidney disease associated with diabetic retinopathy in Asian adults? J Diabetes. (2014) 6:556–63. doi:  10.1111/1753-0407.12148, PMID: [DOI] [PubMed] [Google Scholar]
  • 6. Zhou S, Wang P, Qiao Y, Ge Y, Wang Y, Quan S, et al. Genetic and pharmacologic targeting of glycogen synthase kinase 3beta reinforces the nrf2 antioxidant defense against podocytopathy. J Am Soc Nephrol. (2016) 27:2289–308. doi:  10.1681/ASN.2015050565, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Nikolaidou B, Triantafyllou A, Anyfanti P, Gavriilaki E, Lazaridis A, Dolgyras P, et al. Nighttime systolic blood pressure a major factor of retinal vascular caliber changes in patients with newly diagnosed type 2 diabetes mellitus. Am J Hypertens. (2025) 38:217–24. doi:  10.1093/ajh/hpaf004, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Tapp RJ, Owen CG, Barman SA, Strachan DP, Welikala RA, Foster PJ, et al. Retinal microvascular associations with cardiometabolic risk factors differ by diabetes status: results from the UK Biobank. Diabetologia. (2022) 65:1652–63. doi:  10.1007/s00125-022-05745-y, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Duan J, Wang C, Liu D, Qiao Y, Pan S, Jiang D, et al. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional survey. Sci Rep. (2019) 9:10408. doi:  10.1038/s41598-019-46857-7, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Cankurtaran V, Inanc M, Tekin K, Turgut F. Retinal microcirculation in predicting diabetic nephropathy in type 2 diabetic patients without retinopathy. Ophthalmologica. (2020) 243:271–9. doi:  10.1159/000504943, PMID: [DOI] [PubMed] [Google Scholar]
  • 11. Surawatsatien N, Pongsachareonnont PF, Kulvichit K, Varadisai A, Somkijrungroj T, Mavichak A, et al. Optical coherence tomography angiography biomarkers in thai patients with diabetic nephropathy: A diabetic eye and kidney diseases (DEK-D) study. Transl Vis Sci Technol. (2023) 12:19. doi:  10.1167/tvst.12.4.19, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Yao H, Li Z. Is preclinical diabetic retinopathy in diabetic nephropathy individuals more severe? Front Endocrinol (Lausanne). (2023) 14:1144257. doi:  10.3389/fendo.2023.1144257, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Luo WM, Su JY, Xu T, Fang ZZ. Prevalence of diabetic retinopathy and use of common oral hypoglycemic agents increase the risk of diabetic nephropathy-A cross-sectional study in patients with type 2 diabetes. Int J Environ Res Public Health. (2023) 20:10.3390/ijerph20054623. doi:  10.3390/ijerph20054623, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. (2022) 102:S1–s127. doi:  10.1016/j.kint.2022.06.008, PMID: [DOI] [PubMed] [Google Scholar]
  • 15. Jiang X, Liu X, Qu X, Zhu P, Wo F, Xu X, et al. Integration of metabolomics and peptidomics reveals distinct molecular landscape of human diabetic kidney disease. Theranostics. (2023) 13:3188–203. doi:  10.7150/thno.80435, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Jung CY, Yoo TH. Pathophysiologic mechanisms and potential biomarkers in diabetic kidney disease. Diabetes Metab J. (2022) 46:181–97. doi:  10.4093/dmj.2021.0329, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. American Diabetes Association Professional Practice C . 2. Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabetes Care. (2024) 47:S20–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Lim JI, Kim SJ, Bailey ST, Kovach JL, Vemulakonda GA, Ying GS, et al. Diabetic retinopathy preferred practice pattern®. Ophthalmology. (2025) 132:P75–p162. doi:  10.1016/j.ophtha.2024.12.020, PMID: [DOI] [PubMed] [Google Scholar]
  • 19. Zhao C, Li H, Yuan Z, Yang Z, Wang T, Wang Y, et al. Research on the correlation between retinal vascular parameters and axial length in children using an AI-based fundus image analysis system. PloS One. (2025) 20:e0324352. doi:  10.1371/journal.pone.0324352, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Shi XH, Dong L, Zhang RH, Zhou DJ, Ling SG, Shao L, et al. Relationships between quantitative retinal microvascular characteristics and cognitive function based on automated artificial intelligence measurements. Front Cell Dev Biol. (2023) 11:1174984. doi:  10.3389/fcell.2023.1174984, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Dong Q, Xu H, Xu P, Liu J, Shen Z. Bioinformatic analysis identifies LPL as a critical gene in diabetic kidney disease via lipoprotein metabolism. Front Endocrinol (Lausanne). (2025) 16:1620032. doi:  10.3389/fendo.2025.1620032, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Aronov M, Allon R, Stave D, Belkin M, Margalit E, Fabian ID, et al. Retinal vascular signs as screening and prognostic factors for chronic kidney disease: A systematic review and meta-analysis of current evidence. J Pers Med. (2021) 11. doi:  10.3390/jpm11070665, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Petropoulos IN, Alam U, Fadavi H, Asghar O, Green P, Ponirakis G, et al. Corneal nerve loss detected with corneal confocal microscopy is symmetrical and related to the severity of diabetic polyneuropathy. Diabetes Care. (2013) 36:3646–51. doi:  10.2337/dc13-0193, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Yang J, Liu Z. Mechanistic pathogenesis of endothelial dysfunction in diabetic nephropathy and retinopathy. Front Endocrinol (Lausanne). (2022) 13:816400. doi:  10.3389/fendo.2022.816400, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Stitt AW, Curtis TM, Chen M, Medina RJ, McKay GJ, Jenkins A, et al. The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res. (2016) 51:156–86. doi:  10.1016/j.preteyeres.2015.08.001, PMID: [DOI] [PubMed] [Google Scholar]
  • 26. Szostak J, Goracy A, Durys D, Dec P, Modrzejewski A, Pawlik A. The role of microRNA in the pathogenesis of diabetic nephropathy. Int J Mol Sci. (2023) 24:10.3390/ijms24076214. doi:  10.3390/ijms24076214, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Saini DC, Kochar A, Poonia R. Clinical correlation of diabetic retinopathy with nephropathy and neuropathy. Indian J Ophthalmol. (2021) 69:3364–8. doi:  10.4103/ijo.IJO_1237_21, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Ebeling P, Koivisto VA. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland. Acta Diabetol. (1997) 34:33–8. doi:  10.1007/s005920050062, PMID: [DOI] [PubMed] [Google Scholar]
  • 29. Girach A, Manner D, Porta M. Diabetic microvascular complications: can patients at risk be identified? A review. Int J Clin Pract. (2006) 60:1471–83. doi:  10.1111/j.1742-1241.2006.01175.x, PMID: [DOI] [PubMed] [Google Scholar]
  • 30. Chen Y, Qi Z, Hou X, Chen L. Optical coherence tomography angiography for assessment of changes of the retina and choroid in different stages of diabetic retinopathy and their relationship with diabetic nephropathy. Endokrynol Pol. (2023) 74:135–9. doi:  10.5603/EP.a2022.0085, PMID: [DOI] [PubMed] [Google Scholar]
  • 31. Yeung L, Wu IW, Sun CC, Liu CF, Chen SY, Tseng CH, et al. Early retinal microvascular abnormalities in patients with chronic kidney disease. Microcirculation. (2019) 26:e12555. doi:  10.1111/micc.12555, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Zhuang X, Cao D, Zeng Y, Yang D, Yao J, Kuang J, et al. Associations between retinal microvasculature/microstructure and renal function in type 2 diabetes patients with early chronic kidney disease. Diabetes Res Clin Pract. (2020) 168:108373. doi:  10.1016/j.diabres.2020.108373, PMID: [DOI] [PubMed] [Google Scholar]
  • 33. Wennmann DO, Hsu HH, Pavenstadt H. The renin-angiotensin-aldosterone system in podocytes. Semin Nephrol. (2012) 32:377–84. doi:  10.1016/j.semnephrol.2012.06.009, PMID: [DOI] [PubMed] [Google Scholar]
  • 34. Samsu N. Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment. BioMed Res Int. (2021) 2021:1497449. doi:  10.1155/2021/1497449, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Koca S, Bozkurt E, Erogul O, Yavasoglu F, Dogan M, Akdogan M. Evaluation of macular and optic disc radial peripapillary vessel density with optical coherence tomography angiography in iron deficiency anemia. Photodiagnosis Photodyn Ther. (2022) 38:102744. doi:  10.1016/j.pdpdt.2022.102744, PMID: [DOI] [PubMed] [Google Scholar]
  • 36. Grosso A, Cheung N, Veglio F, Wong TY. Similarities and differences in early retinal phenotypes in hypertension and diabetes. J Hypertens. (2011) 29:1667–75. doi:  10.1097/HJH.0b013e3283496655, PMID: [DOI] [PubMed] [Google Scholar]
  • 37. Lu Y, Fang R, Xu B, Feng C, Zhu Z, Yu M, et al. A semantic segmentation method to analyze retinal vascular parameters of diabetic nephropathy. Front Med (Lausanne). (2024) 11:1494659. doi:  10.3389/fmed.2024.1494659, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Nusinovici S, Sabanayagam C, Lee KE, Zhang L, Cheung CY, Tai ES, et al. Retinal microvascular signs and risk of diabetic kidney disease in asian and white populations. Sci Rep. (2021) 11:4898. doi:  10.1038/s41598-021-84464-7, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Zhang J, Wu Y, Zhang J, Zhang R, Wang Y, Liu F. ABCA1 deficiency-mediated glomerular cholesterol accumulation exacerbates glomerular endothelial injury and dysfunction in diabetic kidney disease. Metabolism. (2023) 139:155377. doi:  10.1016/j.metabol.2022.155377, PMID: [DOI] [PubMed] [Google Scholar]
  • 40. Wei S, Pan X, Xiao Y, Chen R, Wei J. The unique association between the level of plateletcrit and the prevalence of diabetic kidney disease: a cross-sectional study. Front Endocrinol (Lausanne). (2024) 15:1345293. doi:  10.3389/fendo.2024.1345293, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Lopes de Faria JB, Silva KC, Lopes de Faria JM. The contribution of hypertension to diabetic nephropathy and retinopathy: the role of inflammation and oxidative stress. Hypertens Res. (2011) 34:413–22. doi:  10.1038/hr.2010.263, PMID: [DOI] [PubMed] [Google Scholar]
  • 42. Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia. (2006) 49:1761–9. doi:  10.1007/s00125-006-0297-1, PMID: [DOI] [PubMed] [Google Scholar]
  • 43. Popovic N, Radunovic M, Badnjar J, Popovic T. Fractal dimension and lacunarity analysis of retinal microvascular morphology in hypertension and diabetes. Microvasc Res. (2018) 118:36–43. doi:  10.1016/j.mvr.2018.02.006, PMID: [DOI] [PubMed] [Google Scholar]
  • 44. Zoungas S, de Galan BE, Ninomiya T, Grobbee D, Hamet P, Heller S, et al. Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial. Diabetes Care. (2009) 32:2068–74. doi:  10.2337/dc09-0959, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Singh A, Stewart JM. Pathophysiology of diabetic macular edema. Int Ophthalmol Clin. (2009) 49:1–11. doi:  10.1097/IIO.0b013e31819fd164, PMID: [DOI] [PubMed] [Google Scholar]
  • 46. Yan Y, Yu L, Sun C, Zhao H, Zhang H, Wang Z. Retinal microvascular changes in diabetic patients with diabetic nephropathy. BMC Endocr Disord. (2023) 23:101. doi:  10.1186/s12902-022-01250-w, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Matsuo T. Disappearance of diabetic macular hard exudates after hemodialysis introduction. Acta Med Okayama. (2006) 60:201–5. doi:  10.18926/AMO/30746, PMID: [DOI] [PubMed] [Google Scholar]
  • 48. Brown GC, Brown MM, Hiller T, Fischer D, Benson WE, Magargal LE. Cotton-wool spots. Retina. (1985) 5:206–14. doi:  10.1097/00006982-198500540-00003, PMID: [DOI] [PubMed] [Google Scholar]
  • 49. McLeod D. Why cotton wool spots should not be regarded as retinal nerve fibre layer infarcts. Br J Ophthalmol. (2005) 89:229–37. doi:  10.1136/bjo.2004.058347, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Table1.docx (11.7KB, docx)

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.


Articles from Frontiers in Endocrinology are provided here courtesy of Frontiers Media SA

RESOURCES